

Marinus, a pharmaceutical company, reformulates, develops and commercializes drugs to treat neurological, psychiatric and pain disorders. Among its major competitors, Marinus Pharmaceuticals is ranked in 9th place for NPS while Biogen is 1st, and Intarcia Therapeutics is 2nd.Their current market cap is $373.55M